Oncology & Hematology Coding Alert

Question: How should I report the following case? A patient presented for chemotherapy to treat a primary malignant neoplasm of the nasopharyngeal floor. The patient complained of new onset of extreme fatigue, and the oncologist performed a level-3 office visit to evaluate her. The patient then received a 30-minute gemcitabine infusion followed by a 60-minute cisplatin infusion. We did not supply the drugs. Montana SubscriberAnswer: For the diagnoses indicated, you should report V58.11 (Encounter for antineoplastic chemotherapy), 147.3 (Malignant neoplasm of nasopharynx; anterior wall), and 780.79 (Other malaise and fatigue).The procedure codes and modifiers you should use include:96413 (Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug) for the gemcitabine infusion+96417 (Chemotherapy administration, intravenous infusion technique; each additional sequential infusion [different substance/drug], up to 1 hour [List separately in addition to code for primary procedure]) for the cisplatin infusion99213 (Office or other outpatient visit for the [...]